Navigation Links
Increase in Waist Size Contributes To Increased Risk of Heart Disease

An international study was conducted which proved that a simple measuring tape is an important tool in analyzing the risk of heart disease than body mass index (BMI). // BMI is the composite measure of weight and height.

The study was conducted in 63 countries across the world. The findings were that in men, the risk of heart disease increased by between 21 and 40% for every 14cm increase in waist size. On the other hand women, showed an increase in heart disease risk for every 14.9cm growth in waist size.

This study was conducted among all populations, despite the widely varying waist sizes among the 168,000 people who took part. The findings from the study were presented at the annual conference of the American College of Cardiology in Atlanta. The study was conducted with the help of the 6,000 family doctors who measured the waists of all patients who consulted them along with their detailed medical history.

Jean-Pierre Despres, director of cardiology research at University Laval, Quebec, and a member of the study's executive committee said that this would help in identifying patients most at risk. Body mass index, is not a proper indicator of a person's weight. American footballers weighing upwards of 300lbs may cross the boundary for obesity as measured by their BMI, but be healthy because they carry most of their weight as muscle rather than fat.

He said that the type of fat and where it accumulates is more important than the amount. Fat deposited inside the abdomen results in expanding waistline. It secretes toxins into the bloodstream, raises cholesterol and increases the body's resistance to insulin which is essential for controlling blood sugar. Statistics show that about 30,000 people a year die from obesity-related diseases in Britain. Professor Steve Haffner, from the University of Texas, a member of the study executive, said that it is very important to measure the waist circumference and to maintain it thereby
'"/>




Page: 1 2

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Increase in sugar...decrease in brain function!!!
3. Increase in tobacco deaths
4. Increased Heart Attack Risk From Celebrex,Vioxx
5. Deep Sleep Doesnt Increase Memory
6. Allergy Risk Increased by Kerosene Use
7. IVF technique May Increase The Risk Of Birth Defects
8. Step Aerobics Increases good cholesterol
9. Increase in renal problems
10. Fewer teeth & Increased Ischemic Stroke risk
11. Painkillers Increase Risk of Miscarriage
Post Your Comments:
(Date:5/23/2012)... acne, and they deal with the embarrassing skin ... Accutane or Roaccutane. Now, however, research from Tel ... cause eye infections such as conjunctivitis (pink eye) ... of TAU,s School of Public Health at the ... a connection between acne and eye infections, but ...
(Date:5/23/2012)... Blame it on your genes? Researchers from The Miriam ... variations in certain "obesity genes" tend to eat more meals ... the same types of high fat, sugary foods. , Their ... Nutrition and appearing in the June issue, reveals certain ... been previously linked to obesity may play a role ...
(Date:5/23/2012)... in Sweden shows that phthalates from PVC flooring materials ... suspected to cause asthma and allergies, as well as ... children can ingest these softening agents with food but ... are a group of chemical compounds that occur in ... goods such as toys, cleaning solvents, packaging, etc. Phthalates ...
(Date:5/23/2012)... -- The use of physical restraints in nursing ... that includes more training and supportive materials for ... German study. Despite legal regulations and evidence ... bed rails and belts still are frequently used ... the rate of physical-restraint use in U.S. nursing ...
(Date:5/23/2012)... Researchers in the United Kingdom have determined that ... properties, can be an effective treatment option for ... life-threatening complication that occurs in the majority of ... the leading cause of mortality after the first ... the body repeatedly rejects the transplanted lung tissue. ...
Breaking Medicine News(10 mins):Health News:Common acne medication doubles risk of eye infection 2Health News:'Obesity genes' may influence food choices, eating patterns 2Health News:Phthalates in PVC floors taken up by the body in infants 2Health News:Study Offers Ways to Decrease Use of Restraints at Nursing Homes 2Health News:Study shows antibiotic improves respiratory function in lung transplant patients 2
... Year-to-date, NANJING, China, Nov. 5 /Xinhua-PRNewswire-FirstCall/ -- ... manufacturer and supplier of,branded generic pharmaceuticals and manufacturer ... today reported unaudited,financial results for the quarter ended ... -- Total revenue increased to RMB323.4 million ...
... Genelabs,Technologies, Inc. (Nasdaq: GNLB ) announced today ... at the Acumen BioFin Rodman & Renshaw,9th Annual ... am,Eastern Time. The webcast can be accessed through ... at http://www.Genelabs.com . About Genelabs Technologies ...
... Nov. 5 Cardinal Health, a,global provider of ... of health care, announced that effective today, Mark ... officer of the company,s,Healthcare Supply Chain Services (HSCS) ... W. Henderson, 42, will assume the,additional role of ...
... Data Indicate New HspE7 Promotes More Potent ... 5 /PRNewswire-FirstCall/ - Nventa,Biopharmaceuticals Corporation (TSX:NVN) today ... the 24th International Papillomavirus,conference, the largest annual ... the field of human papillomavirus (HPV), taking ...
... FRANCISCO, Calif., Nov. 5 OTN, a leading,physician ... of products,and services to the community physician market, ... community-based practices, today,announced that Oncology Physician Resource (OPR) ... for another year. Under the extended,agreement, which is ...
... Nov. 5 HealthCoach,( http://www.healthcoach.net ) is pleased ... as Vice President of Consulting. James will drive ... the,adoption of healthy lifestyle habits for both by ... the overall development of,the HealthCoach corporate service offerings. ...
Other Medicine News:Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 2Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 3Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 4Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 5Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 6Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 7Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 8Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 9Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 10Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 11Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 12Health News:Simcere Pharmaceutical Group Reports Third Quarter 2007 Results 13Health News:Cardinal Health Announces Sector Management Change 2Health News:Nventa presents HspE7 data at international HPV conference 2Health News:Nventa presents HspE7 data at international HPV conference 3Health News:Nventa presents HspE7 data at international HPV conference 4Health News:Nventa presents HspE7 data at international HPV conference 5Health News:Oncology Physician Resource (OPR) Extends Agreement With OTN and Onmark as Oncology Services Partner 2Health News:Oncology Physician Resource (OPR) Extends Agreement With OTN and Onmark as Oncology Services Partner 3Health News:HealthCoach Welcomes James Herrera as Vice President of Consulting 2
(Date:5/22/2012)... Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ), ... commercialization of products for central nervous system disorders, ... at the Society for Research on Biological Rhythms ... The first poster entitled Pleiomorphic Expression of ... insight into the challenges faced by individuals suffering ...
(Date:5/22/2012)... ALLEGAN, Mich., May 22, 2012  Perrigo Company ... final approval from the U.S. Food and Drug ... for butoconazole nitrate 2% vaginal cream, the generic ... submit a substantially complete ANDA with a paragraph ... marketing exclusivity. Perrigo is working exclusively with KV Pharmaceutical ...
(Date:5/22/2012)... Generics, a division of Prodigy Health Supplier Corporation ... generic equivalent of the branded drug Camptosar by ... Laboratories to develop a portfolio of oncology products. ... developed through the partnership that will add consistent ... market, which has experienced record levels of shortages ...
Breaking Medicine Technology:Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 2Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 3Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 2Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 1GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 2GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 4ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 1ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 1MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 3MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 4
... 22 /PRNewswire-FirstCall/ - Alfacell Corporation,(Nasdaq: ACEL ) ... International,Journal of Oncology (2007; Vol. 31, Issue 3: ... (ROI) in,normal cell types and tumor cell lines. ... to its cytotoxic effect on cancer cells and,mechanistic ...
... Women to Evaluate QuatRx,s ... ANN ARBOR, Mich., Aug. 22 QuatRx Pharmaceuticals, ... compounds to treat endocrine, metabolic and,cardiovascular disorders, today ... Phase 3 clinical trial of Ophena(TM) (ospemifene), the,company,s ...
Other Medicine Technology:Paper in International Journal of Oncology Reports Alfacell's ONCONASE(R) Suppresses Intracellular Oxidative Stress 2Paper in International Journal of Oncology Reports Alfacell's ONCONASE(R) Suppresses Intracellular Oxidative Stress 3QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome 2QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome 3
... NGAL (neutrophil gelatinase-associated lipocalin, lipocalin-2) is ... injury, predicting acute renal failure with a ... increased, especially in urine, as early as ... NGAL an ideal diagnostic marker for acute ...
... 253 is an assayed quality control material ... hemoglobin and hemoglobin fractions on CO-Oximeter instrumentation. ... a control that parallels the human physiologic ... 253 is available in three (3) levels ...
... QC 233 is an ... for monitoring the measurements of ... on CO-Oximeter instrumentation. It is ... for monitoring analyzer performance at ...
... 623 is an assayed quality control material for ... in four (4) levels for monitoring analyzer performance ... may be used on multiple test analyzers (such ... Radiometer 600). QC623 is also for use on ...
Medicine Products: